U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
148501148501A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered TogetherCompletedNo Results AvailableSolid Tumors|Breast Cancer|NeoplasmsDrug: SU011248; Capecitabinehttps://ClinicalTrials.gov/show/NCT00618124
148502148502A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed ConditionsCompletedNo Results AvailableNausea|VomitingDrug: Granisetronhttps://ClinicalTrials.gov/show/NCT00618111
148503148503Study of OCTAPLEX and FFP in Patients Under Vit K Therapy Antagonist Needing Urgent Surgery or Invasive ProceduresCompletedNo Results AvailableReversal of Anticoagulant TreatmentDrug: prothrombin complex concentrate|Biological: Fresh Frozen Plasmahttps://ClinicalTrials.gov/show/NCT00618098
148504148504Motor Imagery Practice in Neurological RehabilitationCompletedNo Results AvailableStroke|Brain Injury|Multiple SclerosisBehavioral: Motor imagery practice|Other: Standard physiotherapy and occupational therapyhttps://ClinicalTrials.gov/show/NCT00618085
148505148505EMPOWIR:Enhance the Metabolic Profile of Women With Insulin ResistanceCompletedHas ResultsHyperinsulinemia|Insulin Resistance|ObesityDrug: metformin and rosiglitazonehttps://ClinicalTrials.gov/show/NCT00618072
148506148506Bioequivalency Study of 7.5 mg Pilocarpine Under Fed ConditionsCompletedNo Results AvailableDry MouthDrug: Pilocarpinehttps://ClinicalTrials.gov/show/NCT00618059
148507148507Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNo Results AvailableSeizures|EpilepsyDrug: Oxcarbazepinehttps://ClinicalTrials.gov/show/NCT00618046
148508148508Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis PatientsCompletedNo Results AvailableHemodialysis|ESRDProcedure: Hemodialysishttps://ClinicalTrials.gov/show/NCT00618033
148509148509Safety and Efficacy of the CiTopâ„¢ Guidewire for Crossing Chronic Total Occlusions in Coronary ArteriesCompletedNo Results AvailableCoronary OcclusionDevice: CiTop(tm) Guidewirehttps://ClinicalTrials.gov/show/NCT00618020
148510148510Effect of PF-00734200 in Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: PF-00734200 30 mg QD|Drug: PF-00734200 20 mg QD|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00618007
148511148511Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With PsoriasisCompletedNo Results AvailablePlaque PsoriasisDrug: INCB018424https://ClinicalTrials.gov/show/NCT00617994
148512148512Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)Active, not recruitingNo Results AvailableHepatocellular CarcinomaDrug: ThermoDox|Drug: 5% Dextrose Solutionhttps://ClinicalTrials.gov/show/NCT00617981
148513148513GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast CancerCompletedNo Results AvailableBreast NeoplasmsDrug: DOCETAXELhttps://ClinicalTrials.gov/show/NCT00617968
148514148514Effects of Aprotinin During Cardiac Surgery/Long Term Death RatesCompletedNo Results AvailableCardiac SurgeryDrug: Aprotinin|Drug: Amicarhttps://ClinicalTrials.gov/show/NCT00617955
148515148515Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Carboplatin|Drug: nab-paclitaxel|Drug: trastuzumabhttps://ClinicalTrials.gov/show/NCT00617942
148516148516Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantTerminatedNo Results AvailableCancerBiological: anti-thymocyte globulin|Biological: rituximab|Drug: clofarabine|Procedure: stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00617929
148517148517Hyperspectral Imaging to Assess and Predict Diabetic Foot UlcersCompletedNo Results AvailableDiabetic Foot Ulcershttps://ClinicalTrials.gov/show/NCT00617916
148518148518Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in RosaceaCompletedHas ResultsPapulopustular RosaceaDrug: Azelaic acid|Drug: Vehicle foamhttps://ClinicalTrials.gov/show/NCT00617903
148519148519A Study to Determine the Activity of SCH 717454 in Subjects With Relapsed Osteosarcoma or Ewing's Sarcoma (Study P04720)TerminatedNo Results AvailableOsteosarcoma|Sarcoma, Ewing's|Peripheral Neuroectodermal TumorDrug: SCH 717454 (19D12)https://ClinicalTrials.gov/show/NCT00617890
148520148520Antihypertensive Response to Losartan and Genetic PolymorphismsCompletedNo Results AvailableHypertensionDrug: losartan potassium|Drug: Comparator: Hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00617877
148521148521The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation SyndromeWithdrawnNo Results AvailableOvarian Hyperstimulation SyndromeDrug: Human Albumin Infusion|Drug: Saline Infusionhttps://ClinicalTrials.gov/show/NCT00617864
148522148522Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years OldCompletedHas ResultsInfluenzaBiological: Lot A of Influenza virus vaccine|Biological: Lot B of Influenza virus vaccine|Biological: Lot C of Influenza virus vaccine|Biological: Comparator influenza virus vaccine|Biological: All 3 consecutive lots of influenza virus vaccine pooledhttps://ClinicalTrials.gov/show/NCT00617851
148523148523Celiac Disease PreventionActive, not recruitingNo Results AvailableCeliac DiseaseOther: Optimal gluten introductionhttps://ClinicalTrials.gov/show/NCT00617838
148524148524Feasibility Study of Cryotherapy for Chronic Venous DisordersCompletedNo Results AvailableVenous InsufficiencyOther: cyrotherapy as a cool gel wraphttps://ClinicalTrials.gov/show/NCT00617825
148525148525Safety and Immunogenicity Study of a Liquid Pentavalent Combination VaccineCompletedNo Results AvailableDiphtheria|Tetanus|Pertussis|Hepatitis B|Haemophilus Influenzae Type BBiological: Shan5https://ClinicalTrials.gov/show/NCT00617812
148526148526Biomarkers That Predict Response to High-Dose Aldesleukin in Patients With Metastatic Kidney Cancer or Metastatic MelanomaActive, not recruitingNo Results AvailableKidney Cancer|Melanoma (Skin)Biological: aldesleukin|Genetic: gene expression analysis|Genetic: mutation analysis|Other: flow cytometryhttps://ClinicalTrials.gov/show/NCT00617799
148527148527CPT Testing for Sacral Neuromodulation OutcomesCompletedNo Results AvailableIncontinenceProcedure: Current Perception Threshold (CPT) Testinghttps://ClinicalTrials.gov/show/NCT00617786
148528148528Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedHas ResultsFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal CancerBiological: hu3S193https://ClinicalTrials.gov/show/NCT00617773
148529148529Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)CompletedNo Results AvailableNeisseria Meningitidis (Bacterial Meningitis)|Invasive Pneumococcal Disease (IPD)Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7)|Biological: 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7)|Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT)https://ClinicalTrials.gov/show/NCT00617760
148530148530Efficacy and Tolerability of Zolmitriptan Nasal SprayCompletedNo Results AvailableMigraineDrug: Zolmitriptan|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00617747

* Görseller ve İçerik tekif hakkına sahip olabilir